leukotriene-b4 and Prostatitis

leukotriene-b4 has been researched along with Prostatitis* in 1 studies

Other Studies

1 other study(ies) available for leukotriene-b4 and Prostatitis

Article	Year
The anti-inflammatory effect of montelukast, a cysteinyl leukotriene receptor-1 antagonist, against estradiol-induced nonbacterial inflammation in the rat prostate. Naunyn-Schmiedeberg's archives of pharmacology, 2017, Volume: 390, Issue:2 Topics: Acetates; Animals; Anti-Inflammatory Agents; Chemokine CCL2; Cyclopropanes; Disease Models, Animal; Dose-Response Relationship, Drug; E-Selectin; Estradiol; Gene Expression Regulation; Inflammation Mediators; Interleukin-6; Leukotriene Antagonists; Leukotriene B4; Male; NF-kappa B; Nitric Oxide Synthase Type II; Orchiectomy; Prostate; Prostatitis; Quinolines; Rats, Wistar; Receptors, Leukotriene; Sulfides; Time Factors; Tumor Necrosis Factor-alpha	2017

Article

Year

The anti-inflammatory effect of montelukast, a cysteinyl leukotriene receptor-1 antagonist, against estradiol-induced nonbacterial inflammation in the rat prostate.

Naunyn-Schmiedeberg's archives of pharmacology, 2017, Volume: 390, Issue:2

Topics: Acetates; Animals; Anti-Inflammatory Agents; Chemokine CCL2; Cyclopropanes; Disease Models, Animal; Dose-Response Relationship, Drug; E-Selectin; Estradiol; Gene Expression Regulation; Inflammation Mediators; Interleukin-6; Leukotriene Antagonists; Leukotriene B4; Male; NF-kappa B; Nitric Oxide Synthase Type II; Orchiectomy; Prostate; Prostatitis; Quinolines; Rats, Wistar; Receptors, Leukotriene; Sulfides; Time Factors; Tumor Necrosis Factor-alpha

2017